Cargando…

Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases

Antithrombotic thienopyridines, such as clopidogrel and prasugrel, are prodrugs that undergo a metabolic two-step bioactivation for their pharmacological efficacy. In the first step, a thiolactone is formed, which is then converted by cytochrome P450-dependent oxidation via sulfenic acids to the act...

Descripción completa

Detalles Bibliográficos
Autores principales: Kiebist, Jan, Schmidtke, Kai-Uwe, Schramm, Marina, König, Rosalie, Quint, Stephan, Kohlmann, Johannes, Zuhse, Ralf, Ullrich, René, Hofrichter, Martin, Scheibner, Katrin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470877/
https://www.ncbi.nlm.nih.gov/pubmed/34575790
http://dx.doi.org/10.3390/jof7090752
_version_ 1784574312554954752
author Kiebist, Jan
Schmidtke, Kai-Uwe
Schramm, Marina
König, Rosalie
Quint, Stephan
Kohlmann, Johannes
Zuhse, Ralf
Ullrich, René
Hofrichter, Martin
Scheibner, Katrin
author_facet Kiebist, Jan
Schmidtke, Kai-Uwe
Schramm, Marina
König, Rosalie
Quint, Stephan
Kohlmann, Johannes
Zuhse, Ralf
Ullrich, René
Hofrichter, Martin
Scheibner, Katrin
author_sort Kiebist, Jan
collection PubMed
description Antithrombotic thienopyridines, such as clopidogrel and prasugrel, are prodrugs that undergo a metabolic two-step bioactivation for their pharmacological efficacy. In the first step, a thiolactone is formed, which is then converted by cytochrome P450-dependent oxidation via sulfenic acids to the active thiol metabolites. These metabolites are the active compounds that inhibit the platelet P2Y(12) receptor and thereby prevent atherothrombotic events. Thus far, described biocatalytic and chemical synthesis approaches to obtain active thienopyridine metabolites are rather complex and suffer from low yields. In the present study, several unspecific peroxygenases (UPOs, EC 1.11.2.1) known to efficiently mimic P450 reactions in vitro—but requiring only hydroperoxide as oxidant—were tested for biocatalytic one-pot syntheses. In the course of the reaction optimization, various parameters such as pH and reductant, as well as organic solvent and amount were varied. The best results for the conversion of 1 mM thienopyridine were achieved using 2 U mL(−1) of a UPO from agaric fungus Marasmius rotula (MroUPO) in a phosphate-buffered system (pH 7) containing 5 mM ascorbate, 2 mM h(−1) H(2)O(2) and 20% acetone. The preparation of the active metabolite of clopidogrel was successful via a two-step oxidation with an overall yield of 25%. In the case of prasugrel, a cascade of porcine liver esterase (PLE) and MroUPO was applied, resulting in a yield of 44%. The two metabolites were isolated with high purity, and their structures were confirmed by MS and MS(2) spectrometry as well as NMR spectroscopy. The findings broaden the scope of UPO applications again and demonstrate that they can be effectively used for the selective synthesis of metabolites and late-state diversification of organic molecules, circumventing complex multistage chemical syntheses and providing sufficient material for structural elucidation, reference material, or cellular assays.
format Online
Article
Text
id pubmed-8470877
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher MDPI
record_format MEDLINE/PubMed
spelling pubmed-84708772021-09-27 Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases Kiebist, Jan Schmidtke, Kai-Uwe Schramm, Marina König, Rosalie Quint, Stephan Kohlmann, Johannes Zuhse, Ralf Ullrich, René Hofrichter, Martin Scheibner, Katrin J Fungi (Basel) Article Antithrombotic thienopyridines, such as clopidogrel and prasugrel, are prodrugs that undergo a metabolic two-step bioactivation for their pharmacological efficacy. In the first step, a thiolactone is formed, which is then converted by cytochrome P450-dependent oxidation via sulfenic acids to the active thiol metabolites. These metabolites are the active compounds that inhibit the platelet P2Y(12) receptor and thereby prevent atherothrombotic events. Thus far, described biocatalytic and chemical synthesis approaches to obtain active thienopyridine metabolites are rather complex and suffer from low yields. In the present study, several unspecific peroxygenases (UPOs, EC 1.11.2.1) known to efficiently mimic P450 reactions in vitro—but requiring only hydroperoxide as oxidant—were tested for biocatalytic one-pot syntheses. In the course of the reaction optimization, various parameters such as pH and reductant, as well as organic solvent and amount were varied. The best results for the conversion of 1 mM thienopyridine were achieved using 2 U mL(−1) of a UPO from agaric fungus Marasmius rotula (MroUPO) in a phosphate-buffered system (pH 7) containing 5 mM ascorbate, 2 mM h(−1) H(2)O(2) and 20% acetone. The preparation of the active metabolite of clopidogrel was successful via a two-step oxidation with an overall yield of 25%. In the case of prasugrel, a cascade of porcine liver esterase (PLE) and MroUPO was applied, resulting in a yield of 44%. The two metabolites were isolated with high purity, and their structures were confirmed by MS and MS(2) spectrometry as well as NMR spectroscopy. The findings broaden the scope of UPO applications again and demonstrate that they can be effectively used for the selective synthesis of metabolites and late-state diversification of organic molecules, circumventing complex multistage chemical syntheses and providing sufficient material for structural elucidation, reference material, or cellular assays. MDPI 2021-09-13 /pmc/articles/PMC8470877/ /pubmed/34575790 http://dx.doi.org/10.3390/jof7090752 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/).
spellingShingle Article
Kiebist, Jan
Schmidtke, Kai-Uwe
Schramm, Marina
König, Rosalie
Quint, Stephan
Kohlmann, Johannes
Zuhse, Ralf
Ullrich, René
Hofrichter, Martin
Scheibner, Katrin
Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases
title Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases
title_full Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases
title_fullStr Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases
title_full_unstemmed Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases
title_short Biocatalytic Syntheses of Antiplatelet Metabolites of the Thienopyridines Clopidogrel and Prasugrel Using Fungal Peroxygenases
title_sort biocatalytic syntheses of antiplatelet metabolites of the thienopyridines clopidogrel and prasugrel using fungal peroxygenases
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8470877/
https://www.ncbi.nlm.nih.gov/pubmed/34575790
http://dx.doi.org/10.3390/jof7090752
work_keys_str_mv AT kiebistjan biocatalyticsynthesesofantiplateletmetabolitesofthethienopyridinesclopidogrelandprasugrelusingfungalperoxygenases
AT schmidtkekaiuwe biocatalyticsynthesesofantiplateletmetabolitesofthethienopyridinesclopidogrelandprasugrelusingfungalperoxygenases
AT schrammmarina biocatalyticsynthesesofantiplateletmetabolitesofthethienopyridinesclopidogrelandprasugrelusingfungalperoxygenases
AT konigrosalie biocatalyticsynthesesofantiplateletmetabolitesofthethienopyridinesclopidogrelandprasugrelusingfungalperoxygenases
AT quintstephan biocatalyticsynthesesofantiplateletmetabolitesofthethienopyridinesclopidogrelandprasugrelusingfungalperoxygenases
AT kohlmannjohannes biocatalyticsynthesesofantiplateletmetabolitesofthethienopyridinesclopidogrelandprasugrelusingfungalperoxygenases
AT zuhseralf biocatalyticsynthesesofantiplateletmetabolitesofthethienopyridinesclopidogrelandprasugrelusingfungalperoxygenases
AT ullrichrene biocatalyticsynthesesofantiplateletmetabolitesofthethienopyridinesclopidogrelandprasugrelusingfungalperoxygenases
AT hofrichtermartin biocatalyticsynthesesofantiplateletmetabolitesofthethienopyridinesclopidogrelandprasugrelusingfungalperoxygenases
AT scheibnerkatrin biocatalyticsynthesesofantiplateletmetabolitesofthethienopyridinesclopidogrelandprasugrelusingfungalperoxygenases